Craft

Lee's Pharm

Stock Price

$1.2

2024-10-29

Market Capitalization

$706.6 M

2024-10-29

Revenue

$1.4 B

FY, 2025

Lee's Pharm Summary

Company Summary

Overview
Lee's Pharm (Lee's Pharmaceutical Holdings) is a company that develops, manufactures, and sells biopharmaceutical products for cardiovascular and infectious diseases areas. It also provides a range of products with a focus on dermatology, oncology, gynecology, ophthalmology, pediatrics, rare diseases, and other sectors.
Type
Public
Status
Active
Founded
1994
HQ
Hong Kong, HK | view all locations
Website
https://www.leespharm.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Lee Siu Fong, Executive Director, Chairman

    • Leelalertsuphakun Wanee, Executive Director, Managing Director, Chief Marketing & Sales Officer

      • Li Xiaoyi, Non-Executive Director, Founder

        • Chan Yau Ching, Independent Non-Executive Director

          Operating MetricsView all

          Products on the Market

          25

          Jun, 2023

          International Partners

          30

          Jun, 2023

          Technology Platforms

          3

          Jun, 2023

          LocationsView all

          2 locations detected

          • Hong Kong, New Territories HQ

            Hong Kong

            Building 20E, Phase 3, Hong Kong Science Park, Shatin

          • Taipei, Taipei City

            Taiwan

            No.36, Songren Road

          Lee's Pharm Financials

          Summary Financials

          Revenue (FY, 2025)
          $1.4B
          Gross profit (FY, 2025)
          $934.0M
          Net income (FY, 2025)
          $50.6M
          Cash (FY, 2025)
          $349.9M
          EBIT (FY, 2025)
          $91.9M
          Enterprise value
          $667.0M

          Footer menu